Similarly, through migration and invasion assays, it was found that BMSCs derived exosomal XIST could promote the migration and invasion by combining miR-655, on this basis, inhibiting the expression of ACLY or treating with SB204990 would reduce the migration and invasion ability of osteosarcoma cells (Fig. 9C). Here, XIST is linked to osteosarcoma.